C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors

TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze, J.D., to its Board of Directors. Howze brings nearly two decades of executive leadership and legal experience across the biotechnology and life-science sectors, including her most recent current service as interim chief executive officer and president of Generation Bio.Continue reading

AZBio Member Spotlight – Gut-Brain Axis Therapeutics

Gut-Brain Axis Therapeutics is developing microbiota transplant therapy for treating gut-brain disorders in autism and related conditions. The company’s founding is deeply personal. Dr. James Adams, who leads the organization, has a daughter with autism, which motivated him 25 years ago to focus his research on treatments for the condition. 15 years ago, he led a study which demonstrated that gastrointestinal symptoms strongly correlated with autism symptoms, and that children with autism were missing beneficial bacteria and had harmful yeast. That led to their first clinical trial of microbiota transplant, which was very successful and led to 5 more, with the last 2 funded by Gut-Brain Axis Therapeutics.Continue reading

Honoring Their Sacrifice – Memorial Day 2026

Memorial Day is a time to remember and honor the men and women who gave their lives in military service to our country. Some died in war time, others died in peacetime. Some died in foreign lands, others died right here at home. We also remember service members who through their injuries, exposure to toxins, or wartime experiences had lives that ended too soon even though they made it home alive. Their sacrifice is the highest price that can be paid for the opportunities we have as Americans. Today, we remember them, honor them, and most if all, should be thankful for the lives that they lived and the sacrifice that they made for us.Continue reading